Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Clostridioides difficile infection (CDI) recurs in 20–35% of patients after treatment of the initial infection, of which up to 60% experience further relapses.
Clostridioides difficile infection (CDI) (recurrent) has a more severe impact on quality of life than Clostridioides difficile infection (CDI) (initial)
…